FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

FDA approves a supplemental application for Diazepam by Natco Pharma USA LLC, approving a supplemental change to the generic diazepam product under ANDA 211998.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Epilepsy
• Muscle Spasms
• Seizure Disorders
• Status Epilepticus

Drugs mentioned

• Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)